Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

Poster display session

126P - Clonal architecture and genomic features of smoking versus non-smoking oncogene driven East-Asian non-small cell lung cancer

Date

15 Oct 2022

Session

Poster display session

Presenters

Chen-Yang Huang

Citation

Annals of Oncology (2022) 33 (suppl_8): S1383-S1430. 10.1016/annonc/annonc1095

Authors

C. Huang1, N. Jiang1, M. Shen2, G. Lai2, A. Takano3, T.K.H. Lim3, W.L. Tam4, A. Skanderup4, D.S.W. Tan2, S.G. Rozen1

Author affiliations

  • 1 Duke-NUS Graduate Medical School, Singapore/SG
  • 2 NCCS - National Cancer Centre Singapore, Singapore/SG
  • 3 SGH - Singapore General Hospital, Singapore/SG
  • 4 A*STAR - Genome Institute of Singapore (GIS), Singapore/SG

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Abstract 126P

Background

Unlike smoking-related lung cancers, oncogene-driven non-small cell lung cancers (NSCLC) are characterized by low mutational burden and complex genomic landscapes. In East Asia, ∼30% of patients with EGFR-driven NSCLC have a history of smoking. This study aims to investigate the impact of tobacco exposure on clonal architecture of EGFR-mutant NSCLC.

Methods

Patients undergoing resection for NSCLC at National Cancer Centre Singapore were enrolled in this study. Clinical information and histopathological features were curated by the Lung Cancer Consortium Singapore. Resected tumors were divided into multiple regions, which then underwent whole-exome sequencing and bulk RNA sequencing. Somatic mutations were called by standard pipelines, and we then investigated tumor phylogeny, mutational burdens, and mutational signatures across the regions from each tumor.

Results

We studied a total of 173 sectors from 48 pts. Majority of pts were ethnic Chinese (n=42, 87.5%) and had early-stage disease (n=47, 97.9%) with adenocarcinoma histology (n=46, 95.8%). Tumors were classified into three groups: “oncogene-driven” non-smoking (n=25, 52%), “oncogene-driven” with smoking history (n=12, 25%) and “typical smoking-related” (n=11, 23%). Oncogene-driven smoking tumors did not differ significantly from oncogene-driven non-smoking tumors in terms of tumor mutation burden, intra-tumoral heterogeneity, or driver mutation pattern. Mutational signature caused by tobacco exposure was prevalent in typical smoking-related tumors but not in oncogene-driven smoking tumors, despite similar smoking histories. Oncogene-driven smoking tumors demonstrated mixed transcriptomic profiles with moderate levels of DNA replicative stress and reduced dependency on proliferative signaling.

Conclusions

The clonal architecture of oncogene-driven tumors with smoking history had low TMB and ITH with SBS4 smoking signature largely absent, genomically appearing similar to archetypical never smoker EGFR-mutant tumors. The mixed transcriptomic phenotype suggests that in the context of oncogene-driven NSCLC, smoking may foster a distinct tumor microenvironment independent of genomic alterations.

Legal entity responsible for the study

The authors.

Funding

National Medical Research Council, Singapore.

Disclosure

All authors have declared no conflicts of interest.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.